Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Oana Joean & Tobias Welte. (2022) Vaccination and modern management of chronic obstructive pulmonary disease – a narrative review. Expert Review of Respiratory Medicine 16:6, pages 605-614.
Read now
Read now
Chunjun Qin, Zhonghua Liu, Meiru Ding, Juntao Cai, Junjie Fu, Jing Hu, Peter H. Seeberger & Jian Yin. (2020) Chemical synthesis of the Pseudomonas aeruginosa O11 O-antigen trisaccharide based on neighboring electron-donating effect. Journal of Carbohydrate Chemistry 39:8, pages 374-397.
Read now
Read now
Sarah M. Baker, James B. McLachlan & Lisa A. Morici. (2020) Immunological considerations in the development of Pseudomonas aeruginosa vaccines. Human Vaccines & Immunotherapeutics 16:2, pages 412-418.
Read now
Read now
Austin Hoggarth, Andrew Weaver, Qinqin Pu, Ting Huang, Jacob Schettler, Feng Chen, Xiefang Yuan & Min Wu. (2019) Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa. Drug Design, Development and Therapy 13, pages 909-924.
Read now
Read now
Robert L Clancy & Allan W Cripps. (2019) An Oral Whole-Cell Killed Nontypeable Haemophilus influenzae Immunotherapeutic For The Prevention Of Acute Exacerbations Of Chronic Airway Disease. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2423-2431.
Read now
Read now
Jordi Rello, Eleonora Bunsow & Antonio Perez. (2016) What if there were no new antibiotics? A look at alternatives. Expert Review of Clinical Pharmacology 9:12, pages 1547-1555.
Read now
Read now
Jordi Rello & Antonio Perez. (2016) Precision medicine for the treatment of severe pneumonia in intensive care. Expert Review of Respiratory Medicine 10:3, pages 297-316.
Read now
Read now
Vincent Le Moigne, Jean-Louis Gaillard & Jean-Louis Herrmann. (2016) Vaccine strategies against cystic fibrosis pathogens. Human Vaccines & Immunotherapeutics 12:3, pages 751-756.
Read now
Read now
Articles from other publishers (45)
Odete R. Mendes. 2023. Viral, Parasitic, Bacterial, and Fungal Infections. Viral, Parasitic, Bacterial, and Fungal Infections
591
608
.
Phillip R. Pittman, Gunnstein Norheim, Benjamin Pierson & Fernando B. Guerena. 2023. Plotkin's Vaccines. Plotkin's Vaccines
172
190.e9
.
Abdelrahman S. Hamad, Eva A. Edward, Eman Sheta, Hamida M. Aboushleib & Mohammed Bahey-El-Din. (2022) Iron Acquisition Proteins of Pseudomonas aeruginosa as Potential Vaccine Targets: In Silico Analysis and In Vivo Evaluation of Protective Efficacy of the Hemophore HasAp. Vaccines 11:1, pages 28.
Crossref
Crossref
Mohammad P. Jamshidi, Chantelle Cairns, Simon Chong, Frank St. Michael, Evgeny V. Vinogradov, Andrew D. Cox & Janelle Sauvageau. (2022)
Synthesis and Immunogenicity of a Methyl Rhamnan Pentasaccharide Conjugate from
Pseudomonas aeruginosa
A-Band Polysaccharide
. ACS Infectious Diseases 8:7, pages 1347-1355.
Crossref
Crossref
Salah A. Sheweita, Amro A. Amara, Heba Gamal, Amany A. Ghazy, Ahmed Hussein & Mohammed Bahey-El-Din. (2022) Bacterial Ghosts of Pseudomonas aeruginosa as a Promising Candidate Vaccine and Its Application in Diabetic Rats. Vaccines 10:6, pages 910.
Crossref
Crossref
Zennia Jean C. Gonzaga, Jinyong Zhang & Bernd H. A. Rehm. (2022)
Intranasal Delivery of Antigen-Coated Polymer Particles Protects against
Pseudomonas aeruginosa
Infection
. ACS Infectious Diseases 8:4, pages 744-756.
Crossref
Crossref
Fatemeh Esmaeilzadeh & Shirin Mahmoodi. (2022) A Novel Design of Multi-epitope Peptide Vaccine Against Pseudomonas
aeruginosa. Letters in Drug Design & Discovery 19:4, pages 304-313.
Crossref
Crossref
Zhaofei Guo, Yining Zhu, Guangsheng Du, Ming Qin, Chunting He, Penghui He, Yuanshuai Song, Wenfei Chen, Shuting Bai, Fuhua Wu, Nan Qiao, Min Jiang, Xianjin Luo, Yuandong Zhang, Tao Gong, Zhirong Zhang & Xun Sun. (2022) Rapid development of a subunit nano-vaccine against drug-resistant Pseudomonas aeruginosa with effective cross-protection. Nano Today 43, pages 101398.
Crossref
Crossref
Rajashree Sahoo, A. Swaroop Sanket, Sanghamitra Pati, Rajni Kant & Gaurav Raj Dwivedi. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
321
344
.
Peng Li, Xiuran Wang, Xiangwan Sun, Ziqiang Guan & Wei Sun. (2021) Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection. mSphere 6:5.
Crossref
Crossref
Peng Li, Xiuran Wang, Xiangwan Sun, Jesse Cimino, Ziqiang Guan & Wei Sun. (2021)
Recombinant
Pseudomonas
Bionanoparticles Induce Protection against Pneumonic Pseudomonas aeruginosa Infection
. Infection and Immunity 89:11.
Crossref
Crossref
Nabamita Basu & Rina Ghosh. (2021) Recent chemical syntheses of bacteria related oligosaccharides using modern expeditious approaches. Carbohydrate Research 507, pages 108295.
Crossref
Crossref
Debaki R. Howlader, Sayan Das, Ti Lu, Gang Hu, David J. Varisco, Zackary K. Dietz, Sierra P. Walton, Siva Sai Kumar Ratnakaram, Francesca M. Gardner, Robert K. Ernst, William D. Picking & Wendy L. Picking. (2021) Effect of Two Unique Nanoparticle Formulations on the Efficacy of a Broadly Protective Vaccine Against Pseudomonas Aeruginosa. Frontiers in Pharmacology 12.
Crossref
Crossref
Rahman Laibi Chelab. 2021. Pseudomonas aeruginosa - Biofilm Formation, Infections and Treatments. Pseudomonas aeruginosa - Biofilm Formation, Infections and Treatments.
Li Gao, Ke-Ru Qin, Ting Li, Hai-Long Wang & Min Pang. (2020) The clinical phenotype of bronchiectasis and its clinical guiding implications. Experimental Biology and Medicine 246:3, pages 275-280.
Crossref
Crossref
Maite Sainz-Mejías, Irene Jurado-Martín & Siobhán McClean. (2020) Understanding Pseudomonas aeruginosa–Host Interactions: The Ongoing Quest for an Efficacious Vaccine. Cells 9:12, pages 2617.
Crossref
Crossref
Sayan Das, Debaki R. Howlader, Qi Zheng, Siva Sai Kumar Ratnakaram, Sean K. Whittier, Ti Lu, Johnathan D. Keith, William D. Picking, Susan E. Birket & Wendy L. Picking. (2020) Development of a Broadly Protective, Self-Adjuvanting Subunit Vaccine to Prevent Infections by Pseudomonas aeruginosa. Frontiers in Immunology 11.
Crossref
Crossref
Sargol Aminnezhad, Ahya Abdi-Ali, Tooba Ghazanfari, Mojgan Bandehpour & Mahboobe Zarrabi. (2020) Immunoinformatics design of multivalent chimeric vaccine for modulation of the immune system in Pseudomonas aeruginosa infection. Infection, Genetics and Evolution 85, pages 104462.
Crossref
Crossref
Yasaman Ahmadbeigi, Alireza Salimi Chirani, Neda Soleimani, Mehdi Mahdavi & Mehdi Goudarzi. (2020) Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization. Molecular Immunology 124, pages 70-82.
Crossref
Crossref
Diego Severiche-Bueno, Enrique Gamboa, Luis F. Reyes & Sanjay H. Chotirmall. (2019) Hot topics and current controversies in non-cystic fibrosis bronchiectasis. Breathe 15:4, pages 286-295.
Crossref
Crossref
Emel Sen-Kilic, Catherine B. Blackwood, Dylan T. Boehm, William T. Witt, Aaron C. Malkowski, Justin R. Bevere, Ting Y. Wong, Jesse M. Hall, Shelby D. Bradford, Melinda E. Varney, Fredrick Heath Damron & Mariette Barbier. (2019) Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia. Frontiers in Immunology 10.
Crossref
Crossref
Majela Gonzalez-Miro, Shuxiong Chen, Zennia Jean Gonzaga, Benjamin Evert, David Wibowo & Bernd H. A. Rehm. (2019) Polyester as Antigen Carrier toward Particulate Vaccines. Biomacromolecules 20:9, pages 3213-3232.
Crossref
Crossref
Mona A. Elhosary, Mohammed Bahey-El-Din, Amany AbdelBary, Nadia El Guink & Hamida M. Aboushleib. (2019) Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model. Microbial Pathogenesis 131, pages 181-185.
Crossref
Crossref
Julia Aguilera-Herce, Meritxell García-Quintanilla, Rocío Romero-Flores, Michael J. McConnell & Francisco Ramos-Morales. (2019)
A Live
Salmonella
Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
. mSphere 4:2.
Crossref
Crossref
Kerry-Ann F. O'Grady, Allan W. Cripps & Keith Grimwood. (2019) Paediatric and adult bronchiectasis: Vaccination in prevention and management. Respirology 24:2, pages 107-114.
Crossref
Crossref
Jimin Kim, Yong-Jae Kim & Jae Wha Kim. (2019) Bacterial Clearance Is Enhanced by α2,3- and α2,6-Sialyllactose via Receptor-Mediated Endocytosis and Phagocytosis. Infection and Immunity 87:1.
Crossref
Crossref
Zheng Pang, Renee Raudonis, Bernard R. Glick, Tong-Jun Lin & Zhenyu Cheng. (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology Advances 37:1, pages 177-192.
Crossref
Crossref
Emmanuel Faure, Kelly Kwong & Dao Nguyen. (2018) Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?. Frontiers in Immunology 9.
Crossref
Crossref
Feng Yang, Jiang Gu, Jintao Zou, Langhuan Lei, Haiming Jing, Jin Zhang, Hao Zeng, Quanming Zou, Fenglin Lv & Jinyong Zhang. (2018) PA0833 Is an OmpA C-Like Protein That Confers Protection Against Pseudomonas aeruginosa Infection. Frontiers in Microbiology 9.
Crossref
Crossref
Elodie Meynet, David Laurin, Jean Luc Lenormand, Boubou Camara, Bertrand Toussaint & Audrey Le Gouëllec. (2018) Killed but metabolically active Pseudomonas aeruginosa -based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections. Vaccine 36:14, pages 1893-1900.
Crossref
Crossref
Phillip R. Pittman & Stanley A. Plotkin. 2018. Plotkin's Vaccines. Plotkin's Vaccines
149
160.e7
.
Jordi Rello, Claus-Georg Krenn, Gottfried Locker, Ernst Pilger, Christian Madl, Laura Balica, Thierry Dugernier, Pierre-Francois Laterre, Herbert Spapen, Pieter Depuydt, Jean-Louis Vincent, Lajos Bogár, Zsuzsanna Szabó, Barbara Völgyes, Rafael Máñez, Nahit Cakar, Atilla Ramazanoglu, Arzu Topeli, Maria A. Mastruzzo, Abel Jasovich, Christian G. Remolif, Liliana del Carmen Soria, Max A. Andresen Hernandez, Carolina Ruiz Balart, Ildikó Krémer, Zsolt Molnár, Frank von Sonnenburg, Arthur Lyons, Michael Joannidis, Heinz Burgmann, Tobias Welte, Anton Klingler, Romana Hochreiter & Kerstin Westritschnig. (2017) A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients. Critical Care 21:1.
Crossref
Crossref
Rika Gomi, Anurag Sharma, Wenzhu Wu, Biin Sung & Stefan Worgall. (2017) Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection. Vaccine 35:51, pages 7174-7180.
Crossref
Crossref
M. Gholami, A.S. Chirani, S. Razavi, R. Falak & G. Irajian. (2017)
Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from
Pseudomonas aeruginosa
in mice
. Letters in Applied Microbiology 65:5, pages 439-445.
Crossref
Crossref
Feng Yang, Jiang Gu, Liuyang Yang, Chen Gao, Haiming Jing, Ying Wang, Hao Zeng, Quanming Zou, Fenglin Lv & Jinyong Zhang. (2017) Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models. Scientific Reports 7:1.
Crossref
Crossref
Susan J. Pizzutto, Kim M. Hare & John W. Upham. (2017) Bronchiectasis in Children: Current Concepts in Immunology and Microbiology. Frontiers in Pediatrics 5.
Crossref
Crossref
Maria P. Cabral, Patricia García, Alejandro Beceiro, Carlos Rumbo, Astrid Pérez, Miriam Moscoso & Germán Bou. (2017) Design of live attenuated bacterial vaccines based on D-glutamate auxotrophy. Nature Communications 8:1.
Crossref
Crossref
Saeko Hamaoka, Yoshifumi Naito, Hideya Katoh, Masaru Shimizu, Mao Kinoshita, Koichi Akiyama, Atsushi Kainuma, Kiyoshi Moriyama, Ken J. Ishii & Teiji Sawa. (2017)
Efficacy comparison of adjuvants in PcrV vaccine against
Pseudomonas aeruginosa
pneumonia
. Microbiology and Immunology 61:2, pages 64-74.
Crossref
Crossref
Carina Peres, Ana I. Matos, João Conniot, Vanessa Sainz, Eva Zupančič, Joana M. Silva, Luís Graça, Rogério Sá Gaspar, Véronique Préat & Helena F. Florindo. (2017) Poly(lactic acid)-based particulate systems are promising tools for immune modulation. Acta Biomaterialia 48, pages 41-57.
Crossref
Crossref
Diana Gaspar, Carina Peres, Helena Florindo & António Almeida. 2016. Handbook of Polyester Drug Delivery Systems. Handbook of Polyester Drug Delivery Systems
521
561
.
Vikas Goyal, Keith Grimwood, Julie Marchant, I. Brent Masters & Anne B. Chang. (2016) Pediatric bronchiectasis: No longer an orphan disease. Pediatric Pulmonology 51:5, pages 450-469.
Crossref
Crossref
V. Le Moigne, J.-L. Gaillard & J.-L. Herrmann. (2016) Vaccine strategies against bacterial pathogens in cystic fibrosis patients. Médecine et Maladies Infectieuses 46:1, pages 4-9.
Crossref
Crossref
Nareman F. Abu-Baker & Hussein Masoud. (2016) Synthesis, Characterization, and Immunological Properties of LPS-Based Vaccines Composed of O-Polysaccharides Conjugated with Recombinant Exoprotein A from <i>Pseudomonas aeruginosa</i>. Advances in Microbiology 06:04, pages 332-342.
Crossref
Crossref
Maitrayee Chatterjee, C.P. Anju, Lalitha Biswas, V. Anil Kumar, C. Gopi Mohan & Raja Biswas. (2016) Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options. International Journal of Medical Microbiology 306:1, pages 48-58.
Crossref
Crossref
Ji-Won Park, In-Sik Shin, Un-Hwan Ha, Sei-Ryang Oh, Jae-Hong Kim & Kyung-Seop Ahn. (2015) Pathophysiological Changes Induced by Pseudomonas aeruginosa Infection Are Involved in MMP-12 and MMP-13 Upregulation in Human Carcinoma Epithelial Cells and a Pneumonia Mouse Model. Infection and Immunity 83:12, pages 4791-4799.
Crossref
Crossref